
Translational neuroscientist with international research experience in Canada and Korea, specializing in disease mechanisms, genomics interpretation, and clinically relevant biomarker research.
Extensive collaboration with clinical professors across major Korean academic medical centers, enabling effective scientific dialogue and real-world insight generation.
Strong communicator with demonstrated ability to translate complex molecular data into clinically meaningful discussions. Seeking to contribute to Lilly’s hybrid MSL model by bridging scientific evidence and clinical practice.
Project: Synaptic resilience mechanisms in Alzheimer’s disease
• Led mechanistic research on SorCS1-mediated regulation of tau phosphorylation under amyloid pathology
• Designed and executed in vivo studies using transgenic AD mouse models (5xFAD)
• Integrated molecular, biochemical, and behavioral datasets to define disease-relevant mechanisms
• Presented research findings to multidisciplinary scientific audiences
• Contributed to manuscript preparation and scientific data interpretation for publication
• Collaborated with cross-functional research teams within an international academic environment
• Conducted family-based genomic analyses using NGS platforms
• Applied ACMG/AMP guidelines for clinical variant classification and reporting
• Identified pathogenic variants and supported functional validation studies
• Collaborated with clinicians to interpret genomic findings in a patient-care context
• Communicated complex genetic findings to multidisciplinary stakeholders
• Investigated Hedgehog signaling and primary cilia in cancer and neurodevelopment
• Designed molecular and cell-based assays to characterize signaling mechanisms
• Contributed to experimental planning and data interpretation
• Supported publication preparation and internal research presentations
Nayoung Naomi Yi, PhD
Translational Neuroscientist | Clinical Collaboration | Genomics & Precision Medicine | Aspiring Medical Science Liaison
Collaborated with clinical professors and physician-scientists at:
Supported interpretation of genetic mutation data, contributed to clinically relevant research discussions, and participated in multidisciplinary translational research initiatives.
PhD Researcher, Université de Montréal / IRCM
Genomics Researcher, Seoul National University Bundang Hospital
Dear Hiring Manager,
I am writing to express my strong interest in the Medical Science Liaison position at Lilly Korea. With a PhD in translational neuroscience and international research experience spanning Canada and Korea, I am excited about the opportunity to contribute to Lilly’s evolving hybrid MSL model and expanded scientific engagement strategy.
Throughout my research career, I have worked at the interface of molecular science and clinical application. I have collaborated closely with clinical professors and physician-scientists across multiple Korean academic medical centers, including Seoul National University Bundang Hospital, Chungnam National University Hospital, and Seoul National University Hospital. These interactions strengthened my ability to translate complex scientific findings into clinically meaningful dialogue and to understand the real-world needs of physicians managing diverse patient populations.
In addition to mechanistic neuroscience research, I have developed strong expertise in genomics and disease-causing mutation interpretation using clinical datasets. This experience enhanced my appreciation for patient heterogeneity, biomarker-driven decision making, and the importance of evidence-based medical communication. I am particularly motivated by Lilly’s strategic focus on expanding engagement with primary care physicians and leveraging digital tools to accelerate scientific exchange.
I am confident that my scientific rigor, international perspective, and collaborative mindset will allow me to build trusted relationships with scientific experts and contribute meaningful insights to Lilly’s medical strategy. I am eager to grow within Lilly’s medical affairs organization and contribute to improving patient outcomes through impactful scientific engagement.
Thank you very much for your consideration. I would welcome the opportunity to further discuss how my background aligns with Lilly’s mission and this role.
Sincerely,
Nayoung Yi, PhD